MedPath
NMPA Approval

Compound Theophylline and Ephedrine Tablets

国药准字H22026003

April 30, 2020

Drug Information

复方茶碱麻黄碱片

片剂

复方

化学药品

April 30, 2020

Company Information

Applicant Company

通化市利民路1号

Manufacturing Company

通化市通化开发区利民路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方茶碱麻黄碱片 - NMPA 批准文号 | MedPath